AKT1 and kidney cancer: Consistent with our findings, prior research has indicated that PTPN3 overexpression could inhibit kidney cancer progression by suppressing the AKT signaling pathway and served as a favorable prognostic factor in patients with KIRC [24], which is consistent with our results.